Stocks · Healthcare · Biotechnology
Beam Therapeutics Inc. BEAM
$24.50 +0.45% Close, Oct 2, 2026 · NASDAQ · Market cap $2.52B
Strong growth
Next earnings report: Nov 3, 2026
Scroll or pinch to zoom, drag to move. Daily prices adjusted for splits. Markers: E = earnings (green beat, red miss), S = split, D = dividend.
Three things to know
- Revenue over the last four quarters was $156.0M, up 158.9% from a year earlier.
- Operating margin widened to -242.3% from -739.9% a year earlier.
- The stock is in a downtrend: below its 200-day average, with the 50-day average below the 200-day.
PromtFinance scores
Each score is a percentile within the Healthcare sector (0–100). Under each score: how the stock ranks in its sector on every component. As of Oct 5, 2026.
How fast revenue, earnings and cash flow are growing.
- Revenue growth (TTM, YoY)Top 8%
- Revenue growth, 3-year CAGRTop 20%
- Revenue growth accelerationTop 37%
Returns on capital, margins, earnings quality and balance-sheet strength.
- Return on invested capitalBottom 42%
- Gross marginBottom 14%
- Operating marginBottom 22%
- Accruals (lower is better)Bottom 5%
- Interest coverBottom 20%
How cheap the shares are relative to earnings, cash flow and their own history.
- Earnings yieldTop 40%
- Free-cash-flow yieldBottom 30%
- EBITDA / enterprise valueTop 44%
- Sales / enterprise valueBottom 23%
Strength and persistence of the price trend, including versus the S&P 500.
- 12-month return excluding last monthBottom 50%
- 6-month returnBottom 43%
- 1-year return vs S&P 500Bottom 44%
- Distance from 52-week highBottom 45%
- Trend checklist (0–4)Bottom 14%
Earnings surprises and analyst sentiment (estimate-revision history is being collected).
- Average EPS surprise, last 4 quartersTop 27%
- Consecutive EPS beatsBottom 20%
- Share of analysts rating BuyBottom 34%
- Upside to consensus price targetTop 27%
Low volatility, shallow drawdowns, low market sensitivity and modest leverage.
- Volatility, 60 days (lower is better)Bottom 39%
- Maximum drawdown, 3 yearsTop 46%
- Beta vs S&P 500 (lower is better)Bottom 7%
What changed
Latest four quarters versus the same period a year earlier (growth: versus one quarter earlier).
| Measure | Before | Now | |
|---|---|---|---|
| Revenue growth (YoY) | 158.0% | 158.9% | ↑ |
| Gross margin | -557.5% | 18.9% | ↑ |
| Operating margin | -739.9% | -242.3% | ↑ |
| FCF margin | -589.9% | -238.9% | ↑ |
Fundamental momentum
| Measure | Now (TTM) | Year / quarter before | Sector rank | |
|---|---|---|---|---|
| Revenue growth (TTM, YoY) | 158.9% | 158.0% | ↑ | Top 8% |
| Gross margin | 18.9% | -557.5% | ↑ | Bottom 14% |
| Operating margin | -242.3% | -739.9% | ↑ | Bottom 22% |
| Net margin | -54.7% | -661.3% | ↑ | — |
| Free-cash-flow margin | -238.9% | -589.9% | ↑ | — |
| Return on invested capital | -28.6% | — | Bottom 42% | |
| Revenue growth, 3-year CAGR | 31.9% | — | Top 20% |
Quality of earnings and balance sheet
- Accruals (net income − OCF) / assetsLower is better; high accruals can signal weaker earnings quality.
- 19.8%
- Stock-based compensation / revenueA cost to shareholders through dilution.
- -8.2%
- Interest cover (operating income / interest)How many times operating profit covers interest.
- -35.5×
Shareholder returns
- Dividend yield (dividends paid, TTM)
- 0.00%
- Net buyback yield (TTM)
- -0.58%
- Shareholder yield
- -0.58%
- Share count change, 1 year
- +2.3%
- Share count change, 3-year CAGR
- +11.0%
Shareholder yield = dividends + net buybacks over the last four quarters, divided by market cap.
Based on the four quarters through Jun 30, 2026 (filed Aug 4, 2026).
Earnings and expectations
Earnings momentum
- Consecutive EPS beats
- 0
- Beats in the last 8 reports
- 3 of 8
- Average EPS surprise, last 4
- +17.0%
- Average 2-day reaction, last 8
- -1.5%
- Positive 20 days after report
- 3 of 8
Analysts
- Consensus price target
- $59.50
- Target vs current price
- +142.9%
- Analysts with a rating
- 27
- Share rating Buy or Strong Buy
- 67%
- Consensus rating
- Buy
How the stock reacted to recent reports
| Report date | EPS surprise | 2 days | 5 days | 20 days | 60 days |
|---|---|---|---|---|---|
| Aug 4, 2026 | -6.3% | +9.4% | +5.3% | +13.6% | — |
| May 7, 2026 | -4.6% | -2.7% | -1.5% | +1.5% | -19.9% |
| Feb 24, 2026 | +91.2% | +14.0% | +1.3% | -11.2% | -7.1% |
| Nov 4, 2025 | -12.2% | -6.2% | -10.7% | -3.6% | +13.9% |
| Aug 5, 2025 | +3.8% | -2.2% | -10.2% | -14.7% | +38.2% |
| May 6, 2025 | -11.7% | -19.3% | -8.0% | -14.8% | -0.6% |
| Feb 25, 2025 | +12.8% | -3.1% | -18.5% | -22.0% | -42.4% |
| Nov 5, 2024 | -3.5% | -1.8% | +24.6% | +6.7% | +5.0% |
Returns from the close before each report. Past reactions do not determine future ones.
Earnings history
| Report date | EPS | Estimate | Surprise | Revenue |
|---|---|---|---|---|
| Aug 4, 2026 | -$1.18 | -$1.11 | -6.3% | $490,000 |
| May 7, 2026 | -$0.91 | -$0.87 | -4.6% | $31.7M |
| Feb 24, 2026 | -$0.10 | -$1.13 | +91.2% | $114.1M |
| Nov 4, 2025 | -$1.10 | -$0.98 | -12.2% | $9.7M |
| Aug 5, 2025 | -$1.00 | -$1.04 | +3.8% | $8.5M |
| May 6, 2025 | -$1.24 | -$1.11 | -11.7% | $7.5M |
| Feb 25, 2025 | -$1.09 | -$1.25 | +12.8% | $30.1M |
| Nov 5, 2024 | -$1.17 | -$1.13 | -3.5% | $14.3M |
Valuation in context
| Multiple | Now | 5-year median | 5-year percentile | Sector rank (cheapness) |
|---|---|---|---|---|
| EV / Sales | 16.33× | — | — | Bottom 23% |
| Free-cash-flow yield | -14.79% | — | — | Bottom 30% |
| Earnings yield | -3.51% | — | — | Top 40% |
Technical state
Trend checklist
- ✗ Price above 20-day average
- ✗ Price above 50-day average
- ✗ Price above 200-day average
- ✗ 50-day average above 200-day
- ✓ MACD histogram positive
Trend quality
- Days above the 50-day average
- 0
- Days above the 200-day average
- 0
- 50-day average slope (20 days)
- -9.7%
- 200-day average slope (20 days)
- -0.0%
- Distance from 50-day average
- -7.8%
- Distance from 200-day average
- -14.0%
- RSI (14)
- 42.4
- Relative volume
- 0.74×
Risk and drawdowns
- Volatility, 60 days (annualized)
- 61.6%
- Volatility vs own 5-year history
- 23th percentile · Normal for this stock
- Beta vs S&P 500 (2 years, weekly)
- 2.29
- Correlation with S&P 500
- 0.49
- Current drawdown from 1-year high
- -35.4%
- Maximum drawdown, 3 years
- -67.7%
Largest declines in the past six years
| From peak | To low | Decline | Length | Recovery |
|---|---|---|---|---|
| Jul 1, 2021 | Apr 8, 2025 | -89.1% | 946 days | Not yet recovered |
| Feb 8, 2021 | May 10, 2021 | -46.9% | 63 days | 36 days (Jun 30, 2021) |
| Jan 15, 2021 | Jan 26, 2021 | -20.6% | 6 days | 8 days (Feb 5, 2021) |
| Sep 28, 2020 | Oct 2, 2020 | -17.3% | 4 days | 2 days (Oct 6, 2020) |
| Dec 28, 2020 | Dec 31, 2020 | -14.6% | 3 days | 4 days (Jan 7, 2021) |
Declines of 10% or more from a closing high, measured on daily closes.
Financial statements
- Market cap
- $2.52B
- EPS, diluted (TTM)
- -$0.86
- Revenue (TTM)
- $156.0M
- 52-week range
- $20.23 – $38.26
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Revenue | $51.8M | $60.9M | $377.7M | $63.5M | $139.7M |
| Gross profit | -$180.3M | -$250.7M | $377.7M | -$304.0M | $117.4M |
| Operating income | -$392.5M | -$338.5M | -$176.5M | -$415.6M | -$383.7M |
| Net income | -$370.6M | -$289.1M | -$132.5M | -$376.7M | -$80.0M |
| EPS (diluted) | -$5.77 | -$4.13 | -$1.72 | -$4.58 | -$0.81 |
| Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | Q2 2026 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $14.3M | $30.1M | $7.5M | $8.5M | $9.7M | $114.1M | $31.7M | $490,000 |
| Net income | -$96.7M | -$90.4M | -$109.3M | -$102.3M | -$112.7M | $244.3M | -$94.3M | -$122.7M |
| EPS (diluted) | -$1.17 | -$1.09 | -$1.24 | -$1.00 | -$1.10 | $2.33 | -$0.91 | -$1.18 |
| FY 2021 | FY 2022 | FY 2023 | FY 2024 | FY 2025 | |
|---|---|---|---|---|---|
| Operating cash flow | -$66.3M | $22.5M | -$149.2M | -$347.2M | -$345.1M |
| Capital expenditure | -$46.8M | -$49.0M | -$33.7M | -$8.9M | -$14.9M |
| Free cash flow | -$113.1M | -$26.4M | -$182.9M | -$356.2M | -$360.0M |
| Dividends paid | $0 | $0 | $0 | $0 | $0 |
| Net share buybacks | $757.4M | $108.3M | $270.2M | $8.2M | $478.0M |
Cash outflows are shown as negative numbers.
- Cash and short-term investments
- $1.15B
- Total assets
- $1.39B
- Total liabilities
- $319.2M
- Total debt
- $247.4M
- Net debt
- $27.5M
- Shareholders’ equity
- $1.07B
As of Jun 30, 2026 (filed Aug 4, 2026).
Dividends
| Ex-date | Amount | Paid |
|---|---|---|
| Nov 4, 2013 | $0.23 | Dec 2, 2013 |
| Aug 12, 2013 | $0.23 | Sep 3, 2013 |
| May 6, 2013 | $0.23 | Jun 3, 2013 |
| Feb 4, 2013 | $0.23 | Mar 1, 2013 |
| Feb 6, 2012 | $0.21 | Mar 1, 2012 |
Short interest
- Shares sold short
- 25,884,796
- Days to cover
- 12.59
- Change vs previous report
- +0.3%
FINRA short interest, settlement date Sep 15, 2026.